Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cells.

Ana Luiza Guimarães ReisJessica Ruivo MaximinoLuis Alberto de Padua Covas LageHélio Rodrigues GomesJuliana PereiraPaulo Roberto Slud BrofmanAlexandra Cristina SenegagliaCarmen Lúcia Kuniyoshi RebelattoDebora Regina DagaWellingson Silva PaivaGerson Chadi

Published in: Stem cell research & therapy (2024)

Clinicaltrial.gov identifier NCT0291768. Registered 28 September 2016.

Keyphrases

bone marrow
amyotrophic lateral sclerosis
cerebrospinal fluid
end stage renal disease
newly diagnosed
ejection fraction
mesenchymal stem cells
peritoneal dialysis
prognostic factors
stem cells
cell therapy
patient reported